Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.560
-0.010 (-0.64%)
Dec 20, 2024, 4:00 PM EST - Market closed
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $41.38 million as of December 20, 2024. Its market cap has increased by 8.58% in one year.
Market Cap
41.38M
Enterprise Value
30.10M
1-Year Change
8.58%
Ranking
Category
Stock Price
$1.56
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $41.38M, a decrease of -66.80%. That is a compound annual growth rate of -25.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 41.38M | -16.20% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| iCAD, Inc. | 45.86M |
| Omega Therapeutics | 44.63M |
| enVVeno Medical | 44.54M |
| Estrella Immunopharma | 44.50M |
| Lucid Diagnostics | 43.51M |
| ImmuCell | 43.22M |
| Rapid Micro Biosystems | 43.03M |
| Barinthus Biotherapeutics | 42.24M |